Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane R Parnes

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|July 6, 2026
Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild-to-moderate asthmaAnna Lundahl, Jonathan Grigg, Lubna Abuqayyas, et al.
ACR Open Rheumatology|July 28, 2022
Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose StudyLubna Abuqayyas, Laurence E Cheng, Marcia Teixeira Dos Santos, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2025
Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in non-human primatesSong Eun Lee, Hind Bouzid, Cheryl Kwan, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2023
Reply to Lipworth and ChanChristopher S Ambrose, Elliot Israel, Karin Bowen, et al.
The Lancet. Gastroenterology & Hepatology|September 9, 2019
Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled studyMarja-Leena Lähdeaho, Mika Scheinin, Pekka Vuotikka, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2023
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical TrialsJonathan Corren, Andrew Menzies-Gow, Geoffrey Chupp, et al.
The Lancet. Gastroenterology & Hepatology|September 9, 2019
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group studyChristophe Cellier, Gerd Bouma, Tom van Gils, et al.
Allergy|July 29, 2025
Distinct Roles for Thymic Stromal Lymphopoietin (TSLP) and IL-33 in Experimental Eosinophilic EsophagitisAnish Dsilva, Ariel Wagner, Michal Itan, et al.
European Journal of Immunology|September 30, 2011
CD6 attenuates early and late signaling events, setting thresholds for T-cell activationMarta I Oliveira, Carine M Gonçalves, Mafalda Pinto, et al.
The New England Journal of Medicine|May 22, 2014
Effects of an anti-TSLP antibody on allergen-induced asthmatic responsesGail M Gauvreau, Paul M O'Byrne, Louis-Philippe Boulet, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|July 6, 2026
Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild-to-moderate asthmaAnna Lundahl, Jonathan Grigg, Lubna Abuqayyas, et al.
ACR Open Rheumatology|July 28, 2022
Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose StudyLubna Abuqayyas, Laurence E Cheng, Marcia Teixeira Dos Santos, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2025
Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in non-human primatesSong Eun Lee, Hind Bouzid, Cheryl Kwan, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2023
Reply to Lipworth and ChanChristopher S Ambrose, Elliot Israel, Karin Bowen, et al.
The Lancet. Gastroenterology & Hepatology|September 9, 2019
Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled studyMarja-Leena Lähdeaho, Mika Scheinin, Pekka Vuotikka, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2023
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical TrialsJonathan Corren, Andrew Menzies-Gow, Geoffrey Chupp, et al.
The Lancet. Gastroenterology & Hepatology|September 9, 2019
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group studyChristophe Cellier, Gerd Bouma, Tom van Gils, et al.
Allergy|July 29, 2025
Distinct Roles for Thymic Stromal Lymphopoietin (TSLP) and IL-33 in Experimental Eosinophilic EsophagitisAnish Dsilva, Ariel Wagner, Michal Itan, et al.
European Journal of Immunology|September 30, 2011
CD6 attenuates early and late signaling events, setting thresholds for T-cell activationMarta I Oliveira, Carine M Gonçalves, Mafalda Pinto, et al.
The New England Journal of Medicine|May 22, 2014
Effects of an anti-TSLP antibody on allergen-induced asthmatic responsesGail M Gauvreau, Paul M O'Byrne, Louis-Philippe Boulet, et al.
Pageof 5